Compare stocks
Add stockDates End of financial period
| #1 | #2 | #3 | #4 | #5 | #6 | #7 | #8 | |
|---|---|---|---|---|---|---|---|---|
| Remove Pfizer Inc | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 |
Profit ROIC / ROE/ROA / ROE / ROA
| #1 | #2 | #3 | #4 | |
|---|---|---|---|---|
| Pfizer Inc (ROE/ROA) | 36.4% | 40.7% | 42.5% | 42.1% |
Growth Sales and OCF growth / Sales and net income growth
| #1 | #2 | #3 | #4 | |
|---|---|---|---|---|
| Pfizer Inc | -5.1% | -5.4% | -4.4% | 17.7% |
Payout Shareholder distributions / net income
| #1 | #2 | #3 | #4 | #5 | |
|---|---|---|---|---|---|
| Pfizer Inc | 150% | 127% | 123% | 121% | 152% |
Safety Equity/assets and OCF stability / Equity/assets and net income stability
| Balance | Stability | |
|---|---|---|
| Pfizer Inc | 42.6% | 62.2% |
Price Earnings and FCF yield / Earnings and book yield
| Earnings | FCF / Book | |
|---|---|---|
| Pfizer Inc | $2.75 | $6.97 |
